JAK抑制对干扰素-γ诱导类风湿关节炎滑膜成纤维细胞促炎表型的作用
该研究探讨干扰素-γ(IFNγ)诱导类风湿关节炎(RA)滑膜成纤维细胞表达HLA-DR+CD90+促炎表型的机制,并评估JAK抑制的阻断效果。研究发现活化NK细胞来源的IFNγ可诱导该表型,且RA患者中该效应比骨关节炎患者强4倍;JAK抑制能阻止HLA-DR诱导并阻断对T细胞的促炎信号。
要点
- 活化NK细胞来源的IFNγ诱导滑膜成纤维细胞HLA-DR+CD90+促炎表型。
- RA患者该诱导效应对T细胞的激活比骨关节炎患者强4倍。
- JAK抑制可阻止HLA-DR诱导并阻断对T细胞的促炎信号。
核心结论
- HLA-DR+CD90+表型代表RA炎症过程中滑膜成纤维细胞的一种活化状态,可由IFNγ诱导,JAK抑制可靶向该过程。
研究设计与样本
- 研究结合原代人源材料的功能实验与质谱流式及转录组患者数据的生物信息学分析。
主要发现
- 活动性RA患者滑膜组织中存在富集且活化的CD16+ NK细胞。
- 可溶性免疫复合物在新描述的报告细胞模型中被CD16识别,可能参与RA中NK细胞活化。
- 体外NK细胞来源的IFNγ诱导CD90+滑膜成纤维细胞表达HLA-DR,形成分泌细胞因子的HLA-DR+CD90+表型。
- HLA-DR+CD90+滑膜成纤维细胞经超抗原受体交联后可激活CD4+ T细胞。
- 无超抗原时,NK细胞来源IFNγ启动的HLA-DR+CD90+滑膜成纤维细胞激活CD4+ T细胞,RA患者比骨关节炎患者强4倍。
关键数值与推荐
- HLA-DR+CD90+滑膜成纤维细胞在RA患者滑膜中扩增15倍。
- RA患者中HLA-DR+CD90+滑膜成纤维细胞激活CD4+ T细胞的效果比骨关节炎患者强4倍。
临床怎么用
- JAK抑制可能通过阻止滑膜成纤维细胞HLA-DR诱导及对T细胞的促炎信号,干预RA炎症过程。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Findings from recent transcriptome analyses of the synovium of patients with rheumatoid arthritis (RA) have revealed that 15-fold expanded HLA-DR+CD90+ synovial fibroblasts potentially act as key mediators of inflammation. The reasons for the expansion of HLA-DR+CD90+ synovial fibroblasts are unclear, but genetic signatures indicate that interferon-γ (IFNγ) plays a central role in the generation of this fibroblast subset. The present study was undertaken to investigate the generation, function and therapeutically intended blockage of HLA-DR+CD90+ synovial fibroblasts. METHODS: We combined functional assays using primary human materials and focused bioinformatic analyses of mass cytometry and transcriptomics patient data sets. RESULTS: We detected enriched and activated Fcγ receptor type IIIa-positive (CD16+) NK cells in the synovial tissue from patients with active RA. Soluble immune complexes were recognized by CD16 in a newly described reporter cell model, a mechanism that could be contributing to the activation of natural killer (NK) cells in RA. In vitro, NK cell-derived IFNγ induced HLA-DR on CD90+ synovial fibroblasts, leading to an inflammatory, cytokine-secreting HLA-DR+CD90+ phenotype. HLA-DR+CD90+ synovial fibroblasts consecutively activated CD4+ T cells upon receptor crosslinking via superantigens. HLA-DR+CD90+ synovial fibroblasts also activated CD4+ T cells in the absence of superantigens, an effect that was initiated by NK cell-derived IFNγ and that was 4 times stronger in patients with RA compared to patients with osteoarthritis. Finally, JAK inhibition in synovial fibroblasts prevented HLA-DR induction and blocked proinflammatory signals to T cells. CONCLUSION: The HLA-DR+CD90+ phenotype represents an activation state of synovial fibroblasts during the process of inflammation in RA that can be induced by IFNγ, likely generated from infiltrating leukocytes such as activated NK cells. The induction of these proinflammatory, interleukin-6-producing, and likely antigen-presenting synovial fibroblasts can be targeted by JAK inhibition.
引用
- Zhao S, Grieshaber-Bouyer R, Rao DA, et al. Effect of JAK Inhibition on the Induction of Proinflammatory HLA-DR+CD90+ Rheumatoid Arthritis Synovial Fibroblasts by Interferon-γ. Arthritis Rheumatol. 2022. PMID: 34435471. doi:10.1002/art.41958
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。